Learn more

CEFO CO LTD

Overview
  • Total Patents
    31
  • GoodIP Patent Rank
    57,029
About

CEFO CO LTD has a total of 31 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and basic materials chemistry are MEGAKARYON CORP, AUXOCELL LABORATORIES INC and PLATELET BIOGENESIS INC.

Patent filings per year

Chart showing CEFO CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mo Hyun Jung 25
#2 Lee Sun Ray 25
#3 Park Hyun Sook 25
#4 Chu Seol 14
#5 Park Jang Mi 11
#6 Yang Ji Won 11
#7 Lee Jin Yup 7
#8 Park Hyun-Sook 3
#9 Hyun Sook Park 3
#10 Sunray Lee 3

Latest patents

Publication Filing date Title
KR20200042870A Apparatus for producing medium
KR102090100B1 Box for cryopreservation of cryovial
KR20200045744A Cell therapy for Canine bone regeneration using Osteogenic differentiation of brown fat tissue derived stroma cell and methods for producing the same
KR20190124608A Automated cell culturing method
KR20180087870A Cell Therapy for bone regeneration and method of manufacturing the same
WO2018139869A1 Cell therapy product for bone regeneration and preparation method therefor
KR20170001688A 3d method for osteogenic differentiation using hydrogel
KR20160034541A 3d method for osteogenic differentiation using hydrogel
KR20160034540A 3d cell culture system and cell culture method using the same
KR20160018950A A composition for preserving cells comprising plant-derived recombinant human serum albumin and plant peptide
KR20150114220A Composition for promoting the synthesis of extracelluar matrix containing proteins derived from mesenchymal stem cell
KR20150114218A Composition for antioxidation containing proteins derived from mesenchymal stem cell
KR20150107465A Composition for tissue regeneration containing proteins derived from mesenchymal stem cell
KR20150105126A Composition for suppressing immune response containing proteins derived from mesenchymal stem cell
US2015327537A1 Composition comprising plant-derived recombinant human serum albumin, lipids, and plant protein hydrolysates as active ingredients for cryopreservation of stem cells or primary cells
KR20140041249A A composition for cryopreservation of stem cells or primary cells comprising plant-derived human serum albumin, plant protein hydrolysate and lipid